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Edited by Stuart FergusonAbstract SurA is a periplasmic chaperone protein that facili-
tates maturation of integral outer membrane proteins (OMPs).
Short peptides that bind SurA have previously been character-
ized. In this work, an enzyme-linked immunoabsorbent assay-
based competition assay is utilized to demonstrate that binding
of such peptides, presented by peptide-tagged phage, mimics
binding of biological substrates. Two representative unfolded
OMPs, OmpF and OmpG, bind SurA and a core structural
fragment thereof in competition with peptide-tagged phage, and
with the same order-of-magnitude aﬃnity as the peptides.
Additionally, unfolded OmpF and OmpG bind SurA more
tightly than an unfolded water-soluble protein, while folded
proteins have no measurable aﬃnity, demonstrating a speciﬁcity
of SurA for OMP polypeptides.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The SurA protein is a bacterial periplasmic molecular
chaperone that facilitates correct folding of integral outer
membrane proteins (OMPs) [1–3]. Although SurA sequences
typically include two (or in a few cases, only one) prolyl
isomerase domains, it has been demonstrated with E. coli
(Escherichia coli) SurA that the prolyl isomerase domains are
dispensable for biological activity, while the remainder of the
protein is essential [4]. The X-ray crystallographic structure of
E. coli SurA reveals a bipartite structure consisting of core
module which includes the ﬁrst prolyl isomerase domain and a
second satellite prolyl isomerase domain (P2) tethered 25–30* Corresponding author. Fax: +1-650-723-8464.
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doi:10.1016/j.febslet.2004.05.014A distant from the core module [5]. The core domain has an
extended, deep crevice which could accommodate segments of
unfolded polypeptides, suggesting a scenario in which SurA
may bind and stabilize unfolded OMPs at some stage during
their transmembrane translocation, folding, and assembly.
Peptide phage display selection experiments with SurA have
revealed a binding preference for a consensus peptide of the
form aromatic(Ar)-polar–Ar-non-polar-proline. A protein
construct in which the satellite prolyl isomerase domain was
deleted, SurA(DP2), showed a similar preference. Although
pentameric sequences ﬁtting this consensus are rare in bacterial
OMPs, a less restrictive target of the form Ar–random–Ar
(Ar–X–Ar) is common, being prevalent in the ‘‘aromatic
bands’’ that encircle the antiparallel b barrel structures of
OMPs. These results suggested that SurA and its core module
bind preferentially to a peptide sequence motif that is prevalent
in OMPs [6].
A question that arises from phage display selection experi-
ments is whether the peptides that are selected are accurate
mimics of natural substrates. Since the experiment selects on
the basis of peptide aﬃnity for the target protein, sequences
that emerge may have artifactually high aﬃnity. Alternatively,
if the target protein recognizes extended polypeptide segments
in natural substrates, then the 7-mer peptides that were
screened in this particular case may under-represent the nat-
ural binding activity. In the extreme case, peptides selected
through phage display may bind the target protein at a site
distinct from the natural substrate binding site. To address the
question of whether the SurA-binding peptides selected by
phage display are legitimate mimics of biological substrates,
we have utilized a competition assay to demonstrate that (a)
two representative unfolded OMPs bind SurA and SurA(DP2)
competitively with, and with aﬃnities that are the same order-
of-magnitude as, peptides selected by phage display; and fur-
ther, (b) unfolded OMPs bind with signiﬁcantly higher aﬃnity
than either a representative unfolded non-membrane protein
or folded proteins.2. Materials and methods
2.1. Protein expression and puriﬁcation
Mature E. coli SurA protein (amino acids 21–421; SwissProt P21202)
and SurA lacking the second (P2) parvulin-like domain (SurA(DP2),
residues 21–281 and 390–428) were expressed and puriﬁed as described
previously [5,6]. The ATPase fragment of bovine 70 kDa heat shockblished by Elsevier B.V. All rights reserved.
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as described [7]. Glutathione-S-transferase (GST) was expressed from
the pGEX-2T vector and puriﬁed on a glutathione sepharose essen-
tially following the manufacturer’s protocol (Amersham Biosciences).
Reduced carboxymethylated lactalbumin (RCMLA) was purchased
from Sigma Chemical. The heptapeptide of sequence WEYIPNV was
synthesized and puriﬁed by the Stanford Protein and Nucleic Acid
Facility.
Gene fragments encoding mature E. coli OmpF and OmpG proteins
(lacking the signal sequence) were PCR-ampliﬁed from genomic DNA
of E. coli strain K-12 MG1655 [8] and cloned into a pET29b vector
(Novagen) using the NdeI and EcoRI restriction sites of the vector.
Since trial puriﬁcation steps on Ni–NTA resin were not particularly
advantageous, the hexahistidine coding sequences were subsequently
deleted from the vectors and only the native OmpF and OmpG se-
quences were expressed. Puriﬁcation of OmpG protein followed a
published protocol [9] with modiﬁcations. The expression plasmid was
transformed into E. coli strain BL21(DE3) and maintained with 34 lg/
mL kanamycin in Luria–Bertani media. Cells were grown at 37 C to
A600  0:7, then protein expression was induced by addition of IPTG
to 0.4 mM ﬁnal concentration, and incubation was continued for an
additional 3 h at 37 C. Cells were pelleted by centrifugation; cell
pellets were resuspended in TBS buﬀer (50 mM Tris–HCl, pH 7.5, 150
mM NaCl, and 0.5 mM phenylmethyl sulfonyl ﬂuoride (PMSF)) and
sonicated with two bursts of 8-min duration. Soluble and insoluble
fractions were separated by centrifugation at 17 000 g for 40 min.
The pellet fraction containing ompG in inclusion bodies was sus-
pended in 10 mM Tris–HCl, pH 7.5, 1% Triton X-100, and 1 M urea
and re-centrifuged. The pellet was then suspended in 10 mM Tris–HCl,
pH 7.5, and 1 M urea and centrifuged again. The remaining pellet was
solubilized in loading buﬀer (10 mM Tris–HCl, pH 7.5, and 8 M urea)
and clariﬁed by centrifugation and ﬁltration through 0.2-lm ﬁlter. The
soluble material was applied on 20 mL DEAE–Sephacel column pre-
equilibrated in the same buﬀer. The column was washed with loading
buﬀer, followed by loading buﬀer plus 100 mM NaCl. Denatured
OmpG protein was eluted from the column by a step gradient of
loading buﬀer plus 300 mM NaCl. A second, essentially pure fraction
could be recovered with a high-salt wash of 2 M NaCl. The eluted
fraction containing OmpG was dialyzed extensively against 10 mM
Tris–HCl, pH 7.5, concentrated, and stored frozen at )20 C.
Expression of OmpF followed the protocol described above for
OmpG, with the minor diﬀerence that cells were incubated at 25 C for
4 h after induction of expression with IPTG. Cell pellet was resus-
pended in buﬀer A (20 mM Tris–HCl, pH 8, and 10 mM EDTA)
supplemented with 0.5 mM PMSF and sonicated two times for 8 min.
Soluble and insoluble fractions were separated by centrifugation. TheFig. 1. ELISA competition experiment between WEYIPNV-tagged phage and
Að½/Þ ¼ Amax=ð1þ Kapp=½/Þ, as described in Section 2. (A) Concentration of
in absence of competing peptide; (s), 5.6 lM WEYIPNV peptide; (j), 11.1
WEYIPNV peptide computed as described in Section 2. (B) Comparison of ﬁ
the right results from ﬁtting function to all data; for curve extending only to
were omitted.insoluble fraction containing unfolded ompF in inclusion bodies was
washed successively in (a) 50 mL, buﬀer A supplemented with 0.4%
Triton X-100 and 0.4% sodium deoxycholate; (b) 50 mL, buﬀer A
supplemented with 0.8% Triton X-100 and 0.8% sodium deoxycholate;
and (c) 50 mL, buﬀer A with 5 M urea, with soluble and insoluble
fractions separated by centrifugation after each wash. The resulting
pellet was solubilized in 25 mL of buﬀer A+8 M guanidine hydro-
chloride and clariﬁed by centrifugation and ﬁltration through 0.2-lm
ﬁlter. 75 mL of acetone was added to last solution and the resulting
heavy precipitate was pelleted and re-dissolved in buﬀer containing
either 8 M urea or 1% SDS. The re-solubilized ompF protein that
resulted from this procedure could be dialyzed into buﬀered solutions
containing as little as 0.01% SDS.
2.2. Enzyme-linked immunoabsorbent competition assay
Measurement of relative aﬃnities of diﬀerent ligands for SurA or
SurA(DP2) was based on an enzyme-linked immunoabsorbent assay
(ELISA) used previously to determine relative aﬃnities of phage-pre-
sented peptides for the target protein [6]. In initial trials to validate the
assay, phage presenting the heptapeptide WEYIPNV at the amino
terminus of the minor coat protein PIII of bacteriophage M13 (New
England Biolabs) was used as a signal-reporting substrate and the
peptide WEYIPNV was used as a competing ligand. For subsequent
experiments, phage presenting the peptide FTYMPPV was used.
Brieﬂy, including variations on the reported procedure: the wells of 96-
well ELISA plates were coated overnight at 4 C with 100 lL per well
of 100 lg/mL SurA(DP2) or 129 lg/mL SurA protein (i.e., equal vol-
umes of equimolar protein solutions). The following day, protein so-
lutions were discarded and wells were treated for 2 h at 4 C with
‘‘blocking buﬀer’’ that included 5 mg/mL BSA to reduce non-speciﬁc
binding interactions. ELISA plates were washed six times with TBST
buﬀer (50 mM Tris–HCl, 150 mM NaCl, and 0.5% [v/v] Tween 20, pH
7.5). Dilutions of FTYMPPV-tagged phage, along with a constant
concentration of competitor substrates of interest (ompG, ompF,
WEYIPNV, RCMLA, or no-competitor control), were made in a
separate plate which had been treated with blocking buﬀer; the ﬁrst
well contained 1011 pfu per 200 lL of TBST, and 11 sequential
threefold dilutions were made, resulting in a range of 106–1011 pfu
per 200 lL. These mixtures were then applied to ELISA plates pre-
coated with the target protein (SurA or SurA(DP2)) and allowed to
incubate for 1 h at room temperature. Unbound ligands were removed
from the wells by washing, after which horseradish peroxidase-conju-
gated anti-M13 antibody (Pharmacia #27-9411-01) was pipetted into
the wells. After incubation and washing to remove unbound antibody,
freshly prepared horseradish peroxidase substrate (36 lL of 30%
H2O2, added to 21 mL of ‘‘ABTS stock’’: 22 mg 2,2
0-Azino-bisthe peptide WEYIPNV for SurA(DP2). Curves are ﬁts of the function
WEYIPNV peptide for data points: (d), average of two measurements
lM; (), 22.3 lM; (r), 44.6 lM; (), 55.7 lM. Inset: values for KI of
ts for data measured in absence of peptide; curve extending further to
phage concentration of 0.1, the two data points shown in open circles
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citrate, pH 4.0) was added to the ELISA plate wells, and the reaction
was allowed to proceed for approximately 15 min at room tempera-
ture. Product of the horseradish peroxidase reaction was monitored as
optical absorbance at k ¼ 405 nm with a microplate reader. Typically,
duplicate rows having FTYMPPV-tagged phage but no additional
competitor ligand were included as ‘‘no-ligand’’ controls, while in
another row the synthetic peptide WEYIPNV, whose binding to the
target proteins has been characterized [6], was often included as a
‘‘known ligand’’ control.
2.3. Data analysis
Data were analyzed using a model of competitive binding between
phage-presented peptide and competitor ligand. Data for A405 gener-
ated by the colorimetric ELISA assay versus phage dilution/concen-
tration [/] were ﬁt with a function of the form:
A405 ¼ Amax
1þ Kapp½/
using MacCurveFit version 1.5 (Kevin Raner Software, Australia),
where Kapp is the apparent relative dissociation constant, correspond-
ing to the phage concentration at half maximal signal ½/0:5 and Amax is
the maximum value of the absorbance. In the absence of competing
ligand, Kapp becomes Kd, the relative dissociation constant for phage
alone. For assays done in the presence of competing ligand at ﬁxed
concentration [I], the ratio Kapp=Kd, computed as the ratio of the phage
concentrations that give half-maximal signal in the presence and ab-
sence of ligand, respectively, gives the shift in apparent binding con-
stant of phage-presented peptide due to the competing ligand. For
simple competitive inhibition,






where KI is the inhibition constant of the competing ligand. For each
new ligand, a survey of concentrations was used initially to ﬁnd assay
conditions where ½I  KI. Datasets consisting of a series of phage di-
lutions were taken at several diﬀerent inhibitor concentrations and
computed values of KI from the multiple datasets were averaged.Fig. 2. Representative ELISA data for competition experiments be-
tween FTYMPPV-tagged phage and various ligands. Curve ﬁts as
described in Fig. 1. (A) Target protein, SurA. (d), average of two
measurements with FTYMPPV-tagged phage in absence of competing
ligand; competing ligands for other data: (s), 31.4 lM RCMLA; (j),
3.79 lM OmpF; (), 2.44 lM OmpG; (r), 3.4 lM peptide WEY-
IPNV. Note that the RCMLA and OmpF curves nearly overlap, in-
dicating that the ratio of their KI values is approximately equal to the
ratio of their concentrations (31.4/3.79¼ 8.3). Similarly with the
OmpG and WEYIPNV curves. (B) Target protein, SurA(DP2). (d),
average of two measurements with FTYMPPV-tagged phage in ab-
sence of competing ligand; competing ligands for other data: (s), 28.0
lM RCMLA; (j), 3.79 lM OmpF; (), 2.44 lM OmpG; (r), 3.4 lM
peptide WEYIPNV. (C) Target protein, SurA(DP2). (d), FTYMPPV-
tagged phage in absence of competing ligand; (s), 24.8 DM Hsc70
ATPase fragment; (j), 3.4 DM peptide WEYIPNV.3. Results
To validate the ELISA assay as a tool for estimating the
relative aﬃnity of a competing ligand, WEYIPNV-tagged
phage was challenged with a heptapeptide of the same se-
quence (Fig. 1). As expected, the binding curve shifted to the
right (toward higher phage concentration) with increasing
concentration of peptide. To compare alternative functions for




was used, where c is an adjustable parameter. For binding of a
set of ligands to identical sites, c equals 1 for non-cooperative
binding and diﬀers from 1 for cooperative binding. It was
found that in most cases, the function ﬁt the data with a
correlation coeﬃcient R > 0:99 when c ¼ 1, where
R2 ¼ 1 n
P








The function in which c was an adjustable parameter rather
than a constant set equal to 1 ﬁt only slightly better and the
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cedures was generally small. Hence, the former function was
used throughout for data analysis.
The limitations in accuracy inherent to the ﬁtting of a hy-
perbolic function to the data were explored using some of the
more poorly ﬁtting data (Fig. 1B). At phage concentrations
substantially in excess of tenfold higher than ½/0:5, the ELISA
assay signal saturates and decreases from its maximum value
for unknown reasons. This consequently aﬀects both of the
adjustable parameters in the curve ﬁt. In the example shown in
Fig. 1B, when data for the two highest phage concentrations
are omitted, the computed value for ½c0:5 shifts from 2.3 0.8
lM (R ¼ 0:97) using all data to 3.0 0.9 lM (R ¼ 0:98). Al-
though these two values are equal within computed error, the
second is 30% larger than the ﬁrst. Hence, the assay is suﬃ-
ciently robust to distinguish severalfold diﬀerences in aﬃnities
of two ligands measured under identical conditions, but is not
precise enough to distinguish twofold diﬀerences. In this work,
the method is used to parameterize binding aﬃnities that diﬀer
by an order of magnitude.
Values of computed KI at each concentration of WEYIPNV
peptide are shown in Fig. 1 (inset). There is only modest var-
iation over the range of peptide concentrations tested (5.6–56
lM). Averaging all data points gives an estimated value of
KI ¼ 0:67 0:08 lM. This can be compared to the value
1.69 0.15 lM measured by calorimetry at pH 7.3, 20 C [6].
The diﬀerence of roughly twofold in the values may be due to
the diﬀerences in assay conditions (for example, the ELISA
assay uses 0.5% v/v Tween 20 detergent, while no detergent
was present in the calorimetry experiment), the diﬀerence in
the nature of the two assays, and the limitation on accuracy of
absolute values of binding constants discussed above. In the
work that follows, conclusions are based on the relative af-
ﬁnities of diﬀerent ligands when compared to the WEYIPNV
peptide as a reference standard, rather than on the absolute
values of the apparent inhibition constants.
To monitor apparent binding inhibition by candidate SurA
ligands, FTYMPPV-tagged phage was used. Representative
data are shown in Fig. 2 and results are summarized in Table 1.
The KI values for the heptapeptide WEYIPNV are 0.5 0.3
lM for SurA and 0.9 0.5 lM for SurA(DP2), equal within
experimental error to the value determined with the WEY-
IPNV-presenting phage. Binding of two unfolded OMPs sol-
ubilized in aqueous solution, E. coli OmpG and OmpF, was
measured. The apparent aﬃnity of OmpG was similar to thatTable 1
Apparent binding constants derived from ELISA assay data using FTYMPP
Competing ligand Inhibitor concentrations at which ELI
datasets were collected (lM)
For SurA protein
WEYIPNV 0.15, 0.38, 0.70, 0.70
OmpG 0.32, 0.42, 0.50, 0.50
OmpF 2.9, 3.6, 4.8, 6.1, 6.7, 7.0
RCMLA 16.0, 34.9, 39.1, 40.7
For SurA(DP2) protein
WEYIPNV 0.33, 0.50, 0.77, 0.80, 0.86, 1.6, 1.6
OmpG 0.22, 0.24, 0.27, 0.30, 0.60, 1.0
OmpF 1.9, 2.3, 2.6, 2.6, 2.7, 3.4
RCMLA 28.3, 35.7, 50.7of WEYIPNV for binding to both SurA and SurA(DP2), while
the binding of OmpF was severalfold weaker. Binding of
RCMLA, which is often taken as a representative unfolded
soluble protein [10], was measured and found to have an order
of magnitude lower aﬃnity for both SurA or SurA(DP2) than
either of the OMPs. Further, two native soluble proteins were
tested, the ATPase fragment of bovine Hsc70 and GST. Nei-
ther showed any signiﬁcant aﬃnity for SurA or SurA(DP2)
(Fig. 2C and data not shown).4. Discussion
Two diﬀerent unfolded OMPs stabilized in aqueous solvent,
OmpF and OmpG, have been used to characterize in interac-
tions of OMPs with SurA and SurA(DP2). OmpF is a trimeric
OMP [11] whose in vivo maturation is impaired in surA
strains [1]. OmpG is a momomeric OMP whose in vitro folding
has been characterized extensively [9,12].
The data presented here establish several points. First,
OmpF and OmpG both compete with FTYMPPV-tagged
phage for binding to SurA and SurA(DP2), demonstrating that
a peptide selected by phage display mimics OMP binding by
competing for the same binding site.
Second, the relative aﬃnities of unfolded OmpG and OmpF
for SurA and SurA(DP2) are similar in magnitude to the aﬃnity
of the peptide WEYIPNV, arguing that the phage display ex-
periment selected peptides that are representative of OMP af-
ﬁnity; the experiment did not select peptides with anomalously
high or low aﬃnity. Diﬀerence in aﬃnity between OmpG and
OmpF may be intrinsic to the proteins, or it may reﬂect dif-
ferences in the method of solubilization (for example, OmpF
preparations have residual SDS present, while OmpG prepa-
rations are devoid of detergent). It is notable in this context that
among the peptides selected by phage display having the Ar–X–
Ar motif, the sequence WEYIPNV had the highest aﬃnity for
SurA and SurA(DP2), and others spanned approximately an
order of magnitude in aﬃnity, as measured by the ELISA assay
[6]. This illustrates an apparent variation in aﬃnities of peptides
carrying the Ar–X–Ar motif; a similar level of variation for
natural substrates would not be unexpected.
Third, the order-of-magnitude weaker binding of RCMLA,
as compared to OmpF and OmpG, demonstrates substrate
selectivity for OMPs among unfolded polypeptides. This
apparent selectivity is consonant with studies showing aV-tagged phage
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mutant strain, several OMPs, including OmpF, become
preferentially sensitive to trypsin digestion (presumably re-
ﬂecting impaired folding), while several soluble periplasmic
proteins are unaﬀected (suggesting that participation of SurA
in their folding is negligible) [1]. Notably, bovine lactalbumin
does not have any Ar–X–Ar motifs in its amino acid sequence,
whileOmpFhas eight suchmotifs andOmpGhas 14. These data
corroborate the suggestion that the Ar–X–Armotif is a primary
binding target of SurA.
Fourth, SurA and SurA(DP2) speciﬁcally interact with un-
folded polypeptides; they show no measurable aﬃnity for two
native folded proteins that were tested.
Hence, further studies of the interaction of SurA and
SurA(DP2) with short peptides derived from phage display
experiments can be pursued with the assurance that their in-
teractions mimic those natural substrates.Acknowledgements: This work was supported by Grant GM-39928
from the National Institutes of Health to D.B.M.References
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